2,047
Views
8
CrossRef citations to date
0
Altmetric
Articles

Percutaneous lung and liver CT-guided ablation on swine model using microwave ablation to determine ablation size for clinical practice

ORCID Icon, , , , , , , , , ORCID Icon, & show all
Pages 1140-1148 | Received 25 Mar 2021, Accepted 24 Jul 2021, Published online: 05 Aug 2021

References

  • Yuan Z, Wang Y, Zhang J, et al. A meta-analysis of clinical outcomes after radiofrequency ablation and microwave ablation for lung cancer and pulmonary metastases. J Am Coll Radiol. 2019;16(3):302–314.
  • Palussière J, Catena V, Buy X. Percutaneous thermal ablation of lung tumors – radiofrequency, microwave and cryotherapy: where are we going? Diagn Interv Imaging. 2017;98(9):619–625.
  • Ahmed M, Solbiati L, Brace CL, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria—a 10-year update. J Vasc Intervent Radiol. 2014;25(11):1691–1705.e4.
  • Dupuy DE. Microwave ablation compared with radiofrequency ablation in lung tissue-is microwave not just for popcorn anymore? Radiology. 2009;251(3):617–618.
  • Hines-Peralta AU, Pirani N, Clegg P, et al. Microwave ablation: results with a 2.45-GHz applicator in ex vivo bovine and in vivo porcine liver. Radiology. 2006;239(1):94–102.
  • Simo KA, Tsirline VB, Sindram D, et al. Microwave ablation using 915-MHz and 2.45-GHz systems: what are the differences? HPB. 2013;15(12):991–996.
  • Lubner MG, Brace CL, Hinshaw JL, et al. Microwave tumor ablation: mechanism of action, clinical results, and devices. J Vasc Intervent Radiol. 2010;21(8 Suppl):S192–S203.
  • Benson AB, Venook AP, Al-Hawary MM, Arain MA, et al. Colon cancer, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021;19(3):329–359.
  • Benson AB, D'Angelica MI, Abbott DE, et al. Guidelines insights: hepatobiliary cancers, version 2.2019. J Natl Compr Canc Netw. 2019;17(4):302–310.
  • Carberry GA, Nocerino E, Cristescu MM, et al. Microwave ablation of the lung in a porcine model: vessel diameter predicts pulmonary artery occlusion. Cardiovasc Intervent Radiol. 2017;40(10):1609–1616.
  • Yu NC, Raman SS, Kim YJ, et al. Microwave liver ablation: influence of hepatic vein size on heat-sink effect in a porcine model. J Vasc Intervent Radiol. 2008;19(7):1087–1092.
  • Kim C. Understanding the nuances of microwave ablation for more accurate post-treatment assessment. Future Oncol. 2018;14(17):1755–1764.
  • Schramm W, Yang D, Haemmerich D. Contribution of direct heating, thermal conduction and perfusion during radiofrequency and microwave ablation. In: 2006 International Conference of the IEEE Engineering in Medicine and Biology Society [Internet]. New York, NY: IEEE; 2006 [cited 2020 Aug 25]. p. 5013–5016. Available from: http://ieeexplore.ieee.org/document/4462929/
  • Vogl TJ, Roman A, Nour Eldin NEA, et al. Comparison between 915 MHz and 2450 MHz microwave ablation systems for the treatment of small diameter lung metastases. Diagn Intervent Radiol. 2018;24(1):31–37.
  • Ringe KI, Lutat C, Rieder C, et al. Experimental evaluation of the heat sink effect in hepatic microwave ablation. PLOS One. 2015;10(7):e0134301.
  • Vogl TJ, Basten LM, Nour-Eldin N-EA, et al. Microwave ablation (MWA) of pulmonary neoplasms: clinical performance of high-frequency MWA with spatial energy control versus conventional low-frequency MWA. Am J Roentgenol. 2019;213(6):1388–1396.
  • Bhardwaj N, Strickland AD, Ahmad F, et al. A comparative histological evaluation of the ablations produced by microwave, cryotherapy and radiofrequency in the liver. Pathology. 2009;41(2):168–172.
  • Brace CL, Diaz TA, Hinshaw JL, et al. Tissue contraction caused by radiofrequency and microwave ablation: a laboratory study in liver and lung. J Vasc Intervent Radiol. 2010;21(8):1280–1286.
  • Amabile C, Ahmed M, Solbiati L, et al. Microwave ablation of primary and secondary liver tumours: ex vivo, in vivo, and clinical characterisation. Int J Hyperthermia. 2017;33(1):34–42.
  • Shyn PB, Bird JR, Koch RM, et al. Hepatic microwave ablation zone size: correlation with total energy, net energy, and manufacturer-provided chart predictions. J Vasc Intervent Radiol. 2016;27(9):1389–1396.
  • Ruiter SJS, Heerink WJ, de Jong KP. Liver microwave ablation: a systematic review of various FDA-approved systems. Eur Radiol. 2019;29(8):4026–4035.
  • Prud’homme C, Teriitehau C, Adam J, et al. Lung microwave ablation – an in vivo swine tumor model experiment to evaluate ablation zones. Int J Hyperthermia. 2020;37(1):879–886.
  • Wang Y, Liu B, Cao P, et al. Comparison between computed tomography-guided percutaneous microwave ablation and thoracoscopic lobectomy for stage I non-small cell lung cancer: MWA vs. lobectomy for early NSCLC. Thorac Cancer. 2018;9(11):1376–1382.
  • Sotirchos VS, Petrovic LM, Gönen M, et al. Colorectal cancer liver metastases: biopsy of the ablation zone and margins can be used to predict oncologic outcome. Radiology. 2016;280(3):949–959.
  • Kurilova I, Bendet A, Petre EN, et al. Factors associated with local tumor control and complications after thermal ablation of colorectal cancer liver metastases: a 15-year retrospective cohort study. Clinical Colorectal Cancer. 2021;20(2):e82–e95.
  • Kim Y, Lee WJ, Rhim H, et al. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (>2 and <5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion. Am J Roentgenol. 2010;195(3):758–765.
  • Wang X, Sofocleous CT, Erinjeri JP, et al. Margin size is an independent predictor of local tumor progression after ablation of Colon cancer liver metastases. Cardiovasc Intervent Radiol. 2013;36(1):166–175.
  • Shady W, Petre EN, Do KG, et al. Percutaneous microwave versus radiofrequency ablation of colorectal liver metastases: ablation with clear margins (A0) provides the best local tumor control. J Vasc Intervent Radiol. 2018;29(2):268–275.e1.
  • Keil S, Bruners P, Schiffl K, et al. Radiofrequency ablation of liver metastases—software-assisted evaluation of the ablation zone in MDCT: tumor-free follow-up versus local recurrent disease. Cardiovasc Intervent Radiol. 2010;33(2):297–306.
  • Tanis E, Spliethoff JW, Evers DJ, et al. Real-time in vivo assessment of radiofrequency ablation of human colorectal liver metastases using diffuse reflectance spectroscopy. Eur J Surg Oncol. 2016;42(2):251–259.
  • Sotirchos VS, Fujisawa S, Vakiani E, et al. Fluorescent tissue assessment of colorectal cancer liver metastases ablation zone: a potential real-time biomarker of complete tumor ablation. Ann Surg Oncol. 2019;26(6):1833–1840.
  • Calandri M, Yamashita S, Gazzera C, et al. Ablation of colorectal liver metastasis: Interaction of ablation margins and RAS mutation profiling on local tumour progression-free survival. Eur Radiol. 2018;28(7):2727–2734.
  • Kaye EA, Cornelis FH, Petre EN, et al. Volumetric 3D assessment of ablation zones after thermal ablation of colorectal liver metastases to improve prediction of local tumor progression. Eur Radiol. 2019;29(5):2698–2705.
  • Lencioni R, de Baere T, Martin RC, et al. Image-guided ablation of malignant liver tumors: recommendations for clinical validation of novel thermal and non-thermal technologies – a Western perspective. Liver Cancer. 2015;4(4):208–214.
  • Lubner MG, Hinshaw JL, Andreano A, et al. High-powered microwave ablation with a small-gauge, gas-cooled antenna: initial ex vivo and in vivo results. J Vasc Intervent Radiol. 2012;23(3):405–411.
  • Hoffmann R, Rempp H, Erhard L, et al. Comparison of four microwave ablation devices: an experimental study in ex vivo bovine liver. Radiology. 2013;268(1):89–97.
  • Chiang J, Willey BJ, del Rio AM, et al. Predictors of thrombosis in hepatic vasculature during microwave tumor ablation of an in vivo porcine model. J Vasc Intervent Radiol. 2014;25(12):1965–1971.e2.
  • Kashima M, Yamakado K, Takaki H, et al. Complications after 1000 lung radiofrequency ablation sessions in 420 patients: a single center’s experiences. Am J Roentgenol. 2011;197(4):W576–W580.
  • Deshazer G, Merck D, Hagmann M, et al. Physical modeling of microwave ablation zone clinical margin variance: modeling of microwave ablation zone clinical margin variance. Med Phys. 2016;43(4):1764–1776.